You are here

Translation of Endovascular Treatment: An Overview

Original Program Date: August 27, 2015
Estimated Time: 1 hour 2 minutes
Release Date: September 21, 2015

View Activity

Program Overview

This first webinar provides an overview on the topic of acute stroke therapies and is targeted at Interventional Radiologists and Endovascular Neurosurgeons. This activity discussed the following:

  1. Overview of Protocol Changes in Acute Interventional Treatment
  2. Reshaping the Pre-hospital and Emergency Room Process to Provide Timely Access to Treatment
    • Patient Selection Criteria for Acute Interventional Treatment
    • Enhancing Transport and Transfer Policies to Increase Timeliness of Intervention
    • Refining the Notification Process
    • Merging and speeding Therapeutic and Diagnostic Procedures
    • Optimizing the Stroke Team
  3. Overcoming Institutional Barriers
    • Implementing New Procedures and Protocol
    • Negotiating Contractual Obstacles
    • Costs
    • Additional Barriers
  4. Presentation and Discussion Several Case Studies
  5. Audience Questions and Dialogue

Target Audience

Translation of Endovascular Treatment activity is targeted at Interventional Radiologists and Endovascular Neurosurgeons.


Participate individually or as a group. Although this program is not accredited, certificates of attendance will be offered when you complete the evaluation and post-assessment forms. Questions can be directed to There are no fees for participation in this activity.

Content Developed and Presented By

James C. Grotta, MD
Director Stroke Research, Memorial Hermann Hospital
Director, Houston Mobile Stroke Unit Consortium
Houston, Texas

Donald Heck, MD
Internventional Radiologist


The content and views presented in this educational activity are those of the speakers and do not necessarily reflect those of National Stroke Association, and/or Stryker. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Additional Resources

Find a Support Group


Get Involved


For over 30 years we have been the trusted source for free resources and education to the stroke community. Together, we empower survivors and their circle of care to thrive after stroke. Make your tax-deductible donation today to support the growing needs of the stroke community.